The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BRUIN CLL-322: A phase 3 open-label, randomized study of fixed duration pirtobrutinib plus venetoclax and rituximab versus venetoclax and rituximab in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma.
 
Toby A. Eyre
Leadership - Abbvie; AstraZeneca; BeiGene; Gilead Sciences; Incyte; Kite, a Gilead Company; Loxo; Roche; Secura Bio
Honoraria - Abbvie; AstraZeneca; Gilead Sciences; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Gilead Sciences; Incyte; Kite, a Gilead Company; Loxo; Roche; Secura Bio
Speakers' Bureau - Abbvie; AstraZeneca; Incyte; Kite/Gilead; Loxo; Medscape; Peerview; Roche
Research Funding - AstraZeneca; BeiGene
Other Relationship - Loxo
 
Phillip Thompson
Honoraria - Abbvie; Adaptive Biotechnologies; BeiGene; Genentech; Janssen; Lilly O.; Pharmacyclics
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; BeiGene; Genentech; Janssen; Lilly O.; Pharmacyclics
Research Funding - Abbvie; Adaptive Biotechnologies; Genentech; Lilly O.; Pharmacyclics
 
William G. Wierda
Research Funding - Abbvie; Acerta Pharma/AstraZeneca; Bristol-Myers Squibb/Celgene/Juno; Cyclacel; Genentech; Gilead Sciences; GlaxoSmithKline/Novartis; Janssen; Kite, a Gilead Company; Loxo/Lilly; miRagen; Oncternal Therapeutics; Pharmacyclics; Sunesis Pharmaceuticals; Xencor
 
Martin Šimkovič
Honoraria - Abbvie/Genentech; AstraZeneca; Janssen-Cilag
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen
Travel, Accommodations, Expenses - Abbvie; Abbvie; AstraZeneca; Gilead Sciences; Janssen-Cilag; Janssen-Cilag
 
Sebastian Grosicki
No Relationships to Disclose
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; BeiGene; Roche
Research Funding - Acerta Pharma; BeiGene; Epizyme; Janssen-Cilag; MEI Pharma; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics
 
Yucai Wang
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Honoraria - Kite, a Gilead company (Inst)
Consulting or Advisory Role - BeiGene (Inst); Incyte (Inst); Innocare (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Loxo (Inst); TG Therapeutics (Inst)
Research Funding - Genentech (Inst); Genmab (Inst); Incyte (Inst); InnoCare (Inst); Loxo (Inst); MorphoSys (Inst); Novartis (Inst)
 
Heidi Móciková
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen-Cilag; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Pier Luigi Zinzani
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb; Celltrion; EUSA Pharma; Gilead Sciences; Incyte; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Novartis; Roche; Sandoz; Secura BIO; SERVIER; Takeda; TG Therapeutics
Speakers' Bureau - EUSA Pharma; MSD; Novartis
 
Constantine Si Lun Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Loxo/Lilly; Novartis; Pharmacyclics; Roche/Genentech
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); BeiGene (Inst); Janssen-Cilag (Inst)
 
Matthew Steven Davids
Honoraria - Aptitude Health; Axis Medical Education; Bio Ascend; Curio Science; Medscape; Peerview; Physicans' Education Resource; PlatformQ Health; Plexus; Research to Practice
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Ascentage Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech; Genmab; Janssen; Lilly; Merck; MingSight; Ono Pharmaceutical; Secura Bio; Syros Pharmaceuticals; Takeda; TG Therapeutics
Research Funding - AbbVie (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Novartis (Inst); Secura Bio (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Up-to-date royalties
 
Amy E. Chang
Employment - Loxo
Stock and Other Ownership Interests - Lilly
Research Funding - Loxo; Sanofi (I)
Travel, Accommodations, Expenses - Loxo
 
Joana M Oliveira
Employment - Lilly O.
Stock and Other Ownership Interests - Lilly O.
Other Relationship - Lilly O.
 
Yi Lu
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
Travel, Accommodations, Expenses - Lilly
 
Ching Ching Leow
Employment - Loxo/Lilly
Stock and Other Ownership Interests - Lilly O.
 
Lindsey Elizabeth Roeker
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I)
Honoraria - Aptitude Health; DAVA Oncology; OncLive/MJH Life Sciences; Peerview; Pfizer; Prova Education; Vaniam Group
Consulting or Advisory Role - Abbvie; Ascentage Pharma; AstraZeneca; BeiGene; Janssen; Loxo/Lilly; Nurix; Pharmacyclics; Pharmacyclics; TG Therapeutics
Research Funding - Adaptive Biotechnologies (Inst); Aptose Biosciences (Inst); AstraZeneca (Inst); DAAN Biotherapeutics (Inst); Genentech (Inst); Loxo/Lilly (Inst); Pfizer (Inst); Qilu Puget Sound Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Loxo/Lilly; Vaniam Group
 
Jennifer Ann Woyach
Consulting or Advisory Role - AstraZeneca; Beigene; Genentech; Janssen; Loxo; Newave Pharmaceutical; Pharmacyclics
Research Funding - Janssen; Karyopharm Therapeutics; MorphoSys; Schrodinger